TALOXA2
Traitement adjuvant du syndrome de Lennox-Gastaut chez l'adulte et l'enfant de plus de 4 ans, …
Additional information from the official database
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
600.0 MG | Substance | Wirkstoff (Principe actif) |
|
cellulosum microcristallinum
|
- | Substance | HNIDK |
|
amylum pregelificatum
|
- | Substance | HNIDK |
|
lactosum monohydricum
|
60.0 MG | Substance | HBESI |
|
carmellosum natricum conexum
|
- | Substance | HNIDK |
|
natrium
|
- | Substance | HBESI |
|
magnesii stearas
|
- | Substance | HNIDK |
6006 Luzern